Tuberculosis drug development pipeline: progress and hope.
The Global Alliance for TB Drug Development, New York, NY, USA.
Melvin
M
Spigelman
Stephen
S
Gillespie
D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012106:Research; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents